Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Concord Biotech Ltd, Godrej Consumer Products Ltd, Kalyan Jewellers India Ltd, Tata Technologies Ltd are among the other stocks to see a surge in volumes on BSE today, 07 January 2026.
SBI Life Insurance Company Ltd witnessed volume of 4.56 lakh shares by 10:45 IST on BSE, a 18.92 times surge over two-week average daily volume of 24082 shares. The stock increased 0.63% to Rs.2,108.00. Volumes stood at 1.32 lakh shares in the last session.
Concord Biotech Ltd saw volume of 26483 shares by 10:45 IST on BSE, a 7.61 fold spurt over two-week average daily volume of 3478 shares. The stock increased 2.64% to Rs.1,390.45. Volumes stood at 8977 shares in the last session.
Godrej Consumer Products Ltd clocked volume of 1.25 lakh shares by 10:45 IST on BSE, a 6.77 times surge over two-week average daily volume of 18539 shares. The stock lost 0.39% to Rs.1,248.80. Volumes stood at 11492 shares in the last session.
Kalyan Jewellers India Ltd notched up volume of 8.52 lakh shares by 10:45 IST on BSE, a 6.76 fold spurt over two-week average daily volume of 1.26 lakh shares. The stock rose 4.23% to Rs.521.80. Volumes stood at 1.39 lakh shares in the last session.
Tata Technologies Ltd recorded volume of 2.48 lakh shares by 10:45 IST on BSE, a 5.93 times surge over two-week average daily volume of 41874 shares. The stock gained 4.78% to Rs.679.90. Volumes stood at 50107 shares in the last session.
Across leadership roles at Intas Pharmaceuticals, Sakar Healthcare, Lambda Therapeutics, Shalby Hospitals, Gati, GVFL, and Claris Lifesciences, he has delivered significant impact—managing multi billion dollar financing programs, leading India’s largest outbound pharma acquisition, facilitating marquee private equity investments, and executing global audits across Europe, the US, Latin America, and emerging markets.
Concord Biotech is a R&D driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It has a presence in more than 70 countries worldwide.
The company’s consolidated net profit declined 33.6% to Rs 63.58 crore on 20.3% increase in net sales to Rs 247.06 crore in Q2 FY26 over Q2 FY25.
The scrip rose 0.20% to Rs 1335 on the BSE.